Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Biosite, Inc. (NasdaqNM:BSTE)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Location
11030 Roselle Street
San Diego, CA 92121
Phone: (858) 455-4808
Fax: (858) 455-4815
Email: npadilla@biosite.com
Employees (last reported count): 320
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 44%
·Over the last 6 months:
 · 20 insider sells; 466.0K shares
  (6.8% of insider shares)
·Institutional: 78% (139% of float)
(172 institutions)
·Net Inst. Buying: 85.0K shares (+0.75%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Biosite, Inc., formerly known as Biosite Diagnostics, Inc., is a research-based diagnostics company dedicated to the discovery and development of novel protein-based tests that improve a physician's ability to diagnose disease. The Company combines separate, yet integrated discovery and diagnostics businesses to access proteomics research, identify proteins with high diagnostic utility, develop and commercialize products and educate the medical community on new approaches to diagnosis. The Company's diagnostics business is a provider of rapid tests that aid in the diagnosis of a variety of critical diseases. These tests are sold worldwide primarily for use in emergency departments and hospital laboratories. Biosite's two product platforms are designed to provide rapid results through either qualitative visual readings or quantitative meter readings.
More from Market Guide: Expanded Business Description

Financial Summary
Biosite, Inc. develops, manufactures and markets diagnostic products that improve the quality of patient care and simplify the practice of laboratory medicine. For the six months ended 6/30/01, revenues rose 19% to $31.4 million. Net income rose 29% to $3.4 million. Revenues reflect growth in net sales of the company's Triage Cardiac System and sales related to the licensing of technology. Earnings also reflect increased gross profit margins.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Timothy Wollaeger, 57
Chairman
--  --  
Kim Blickenstaff, 48
Pres, CEO, Treasurer, Sec.,
$517K$3.7M
Thomas Watlington, 45
Sr. VP - Commercial Operations
343K61K
Christopher Twomey, 41
VP of Fin. and CFO
310K870K
Peter Witerzens, Ph.D., 59
VP, Operations
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:BSTEAs of 31-Aug-2001
Price and Volume
52-Week Low
on 13-Nov-2000
$20.125
Recent Price$26.47 
52-Week High
on 5-Sep-2000
$75.00 
Beta1.59 
Daily Volume (3-month avg)238.0K
Daily Volume (10-day avg)113.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-63.0%
52-Week Change
relative to S&P500
-50.4%
Share-Related Items
Market Capitalization$384.8M
Shares Outstanding14.5M
Float8.10M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$5.92 
Earnings (ttm)$0.45 
Earnings (mrq)$0.12 
Sales (ttm)$3.87 
Cash (mrq)$3.59 
Valuation Ratios
Price/Book (mrq)4.47 
Price/Earnings (ttm)59.35 
Price/Sales (ttm)6.84 
Income Statements
Sales (ttm)$60.0M
EBITDA (ttm)$8.78M
Income available to common (ttm)$6.93M
Profitability
Profit Margin (ttm)11.5%
Operating Margin (ttm)14.6%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)8.29%
Return on Equity (ttm)9.54%
Financial Strength
Current Ratio (mrq)9.45 
Debt/Equity (mrq)0.06 
Total Cash (mrq)$52.1M
Short Interest
As of 8-Aug-2001
Shares Short1.36M
Percent of Float16.8%
Shares Short
(Prior Month)
964.0K
Short Ratio6.25 
Daily Volume218.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.